The therapeutic effects of human adipose-derived stem cells in a rat cervical spinal cord injury model

Stem Cells and Development

Volumn 23, Issue 14, 2014, Pages 1659-1674

  Kolar, Mallappa K ^a   Kingham, Paul J ^a   Novikova, Liudmila N ^a   Wiberg, Mikael ^a   Novikov, Lev N ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLOSPORIN A; FIBROBLAST GROWTH FACTOR 2; GLIAL FIBRILLARY ACIDIC PROTEIN; NERVE GROWTH FACTOR; NEUROTROPHIN 3; VASCULOTROPIN A;

ADIPOSE DERIVED STEM CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTE CULTURE; CAPILLARY; CELL ACTIVATION; CELL THERAPY; CERVICAL SPINAL CORD INJURY; COCULTURE; CONTROLLED STUDY; DORSAL ROOT; FEMALE; FORELIMB; GANGLION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MICROGLIA; NERVE FIBER; NERVE FIBER GROWTH; NERVE SPROUTING; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHWANN CELL; SCHWANN CELL CULTURE; SPINAL CORD REGENERATION; SPINAL CORD VENTRAL HORN; SPINAL GANGLION; STEM CELL TRANSPLANTATION; THERAPY EFFECT; ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; CERVICAL SPINAL CORD; CYTOLOGY; INJURIES; NERVE REGENERATION; PATHOLOGY; SPINAL CORD INJURIES; STEM CELL; TRANSPLANTATION;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; AXONS; CERVICAL CORD; HUMANS; NERVE REGENERATION; RATS; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84904117287     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0416     Document Type: Article

References (92)

1. van den Berg ME, JM Castellote, I Mahillo-Fernandez and J de Pedro-Cuesta. (2010). Incidence of spinal cord injury worldwide: A systematic review. Neuroepidemiology 34: 184-192.
2. Hall ED. (2011). Antioxidant therapies for acute spinal cord injury. Neurotherapeutics 8:152-167.
3. Horn KP, SA Busch, AL Hawthorne, N van Rooijen and J Silver. (2008). Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions. J Neurosci 28:9330-9341.
4. Bradbury EJ and LM Carter. (2011). Manipulating the glial scar: chondroitinase ABC as a therapy for spinal cord injury. Brain Res Bull 84:306-316.
5. Garcia-Alias G and JW Fawcett. (2012). Training and anti- CSPG combination therapy for spinal cord injury. Exp Neurol 235:26-32.
6. Goritz C, DO Dias, N Tomilin, M Barbacid, O Shupliakov and J Frisen. (2011). A pericyte origin of spinal cord scar tissue. Science 333:238-242.
7. Kawano H, J Kimura-Kuroda, Y Komuta, N Yoshioka, HP Li, K Kawamura, Y Li and G Raisman. (2012). Role of the lesion scar in the response to damage and repair of the central nervous system. Cell Tissue Res 349:169-180.
8. Novikova LN, LN Novikov and JO Kellerth. (2000). Survival effects of BDNF and NT-3 on axotomized rubrospinal neurons depend on the temporal pattern of neurotrophin administration. Eur J Neurosci 12:776-780.
9. Novikova LN, LN Novikov and JO Kellerth. (2000). BDNF abolishes the survival effect of NT-3 in axotomized Clarke neurons of adult rats. J Comp Neurol 428:671-680.
10. Vawda R and MG Fehlings. (2013). Mesenchymal cells in the treatment of spinal cord injury: current and future perspectives. Curr Stem Cell Res Ther 8:25-38.
11. Tetzlaff W, EB Okon, S Karimi-Abdolrezaee, CE Hill, JS Sparling, JR Plemel, WT Plunet, EC Tsai, D Baptiste, et al. (2011). A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma 28:1611-1682.
12. Young HE, ML Mancini, RP Wright, JC Smith, AC Black, CR Reagan and PA Lucas. (1995). Mesenchymal stem cells reside within the connective tissues of many organs. Dev Dyn 202:137-144.
13. Mothe AJ and CH Tator. (2012). Advances in stem cell therapy for spinal cord injury. J Clin Invest 122:3824-3834.
14. Attar A, M Ayten, M Ozdemir, E Ozgencil, M Bozkurt, E Kaptanoglu, M Beksac and Y Kanpolat. (2011). An attempt to treat patients who have injured spinal cords with intralesional implantation of concentrated autologous bone marrow cells. Cytotherapy 13:54-60.
15. Kumar AA, SR Kumar, R Narayanan, K Arul and M Baskaran. (2009). Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data. Exp Clin Transplant 7:241-248.
16. Ra JC, IS Shin, SH Kim, SK Kang, BC Kang, HY Lee, YJ Kim, JY Jo, EJ Yoon, HJ Choi and E Kwon. (2011). Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev 20:1297-1308.
17. Cizkova D, J Rosocha, I Vanicky, S Jergova and M Cizek. (2006). Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat. Cell Mol Neurobiol 26:1167-1180.
18. Hofstetter CP, EJ Schwarz, D Hess, J Widenfalk, A El Manira, DJ Prockop and L Olson. (2002). Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A 99:2199-2204.
19. Chopp M, XH Zhang, Y Li, L Wang, J Chen, D Lu, M Lu and M Rosenblum. (2000). Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 11:3001-3005.
20. Lu P, LL Jones and MH Tuszynski. (2007). Axon regeneration through scars and into sites of chronic spinal cord injury. Exp Neurol 203:8-21.
21. Novikova LN, M Brohlin, PJ Kingham, LN Novikov and M Wiberg. (2011). Neuroprotective and growth-promoting effects of bone marrow stromal cells after cervical spinal cord injury in adult rats. Cytotherapy 13:873-887.
22. Crigler L, RC Robey, A Asawachaicharn, D Gaupp and DG Phinney. (2006). Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 198:54-64.
23. Neuhuber B, B Timothy Himes, JS Shumsky, G Gallo and I Fischer. (2005). Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res 1035:73-85.
24. Urdzikova L, P Jendelova, K Glogarova, M Burian, M Hajek and E Sykova. (2006). Transplantation of bone marrow stem cells as well as mobilization by granulocytecolony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma 23:1379-1391.
25. Cizkova D, I Novotna, L Slovinska, I Vanicky, S Jergova, J Rosocha and J Radonak. (2011). Repetitive intrathecal catheter delivery of bone marrow mesenchymal stromal cells improves functional recovery in a rat model of contusive spinal cord injury. J Neurotrauma 28:1951-1961.
26. Himes BT, B Neuhuber, C Coleman, R Kushner, SA Swanger, GC Kopen, J Wagner, JS Shumsky and I Fischer. (2006). Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord. Neurorehabil Neural Repair 20:278-296.
27. Ankeny DP, DM McTigue and LB Jakeman. (2004). Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Exp Neurol 190:17-31.
28. Son BR, LA Marquez-Curtis, M Kucia, M Wysoczynski, AR Turner, J Ratajczak, MZ Ratajczak and A Janowska- Wieczorek. (2006). Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 24:1254-1264.
29. d'Ortho MP, H Will, S Atkinson, G Butler, A Messent, J Gavrilovic, B Smith, R Timpl, L Zardi and G Murphy. (1997). Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 250: 751-757.
30. Strem BM, KC Hicok, M Zhu, I Wulur, Z Alfonso, RE Schreiber, JK Fraser and MH Hedrick. (2005). Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 54:132-141.
31. Salgado AJ, RL Reis, NJ Sousa and JM Gimble. (2010). Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther 5:103-110.
32. Arboleda D, S Forostyak, P Jendelova, D Marekova, T Amemori, H Pivonkova, K Masinova and E Sykova. (2011). Transplantation of predifferentiated adipose-derived stromal cells for the treatment of spinal cord injury. Cell Mol Neurobiol 31:1113-1122.
33. Chung CS, N Fujita, N Kawahara, S Yui, E Nam and R Nishimura. (2013). A comparison of neurosphere differentiation potential of canine bone marrow-derived mesenchymal stem cells and adipose-derived mesenchymal stem cells. J Vet Med Sci 75:879-886.
34. Zhou Z, Y Chen, H Zhang, S Min, B Yu, B He and A Jin. (2013). Comparison of mesenchymal stromal cells from human bone marrow and adipose tissue for the treatment of spinal cord injury. Cytotherapy 15:434-448.
35. Kalbermatten DF, D Schaakxs, PJ Kingham and M Wiberg. (2011). Neurotrophic activity of human adipose stem cellsisolated from deep and superficial layers of abdominal fat. Cell Tissue Res 344:251-260.
36. Kingham PJ, DF Kalbermatten, D Mahay, SJ Armstrong, M Wiberg and G Terenghi. (2007). Adipose-derived stem cells differentiate into a Schwann cell phenotype and promote neurite outgrowth in vitro. Exp Neurol 207:267-274.
37. Tom VJ, CM Doller, AT Malouf and J Silver. (2004). Astrocyte-associated fibronectin is critical for axonal regeneration in adult white matter. J Neurosci 24:9282-9290.
38. Novikova LN, J Pettersson, M Brohlin, M Wiberg and LN Novikov. (2008). Biodegradable poly-beta-hydroxybutyrate scaffold seeded with Schwann cells to promote spinal cord repair. Biomaterials 29:1198-1206.
39. Brohlin M, D Mahay, LN Novikov, G Terenghi, M Wiberg, SG Shawcross and LN Novikova. (2009). Characterisation of human mesenchymal stem cells following differentiation into Schwann cell-like cells. Neurosci Res 64:41-49.
40. Schira J, M Gasis, V Estrada, M Hendricks, C Schmitz, T Trapp, F Kruse, G Kogler, P Wernet, HP Hartung and HW Muller. (2012). Significant clinical, neuropathological and behavioural recovery from acute spinal cord trauma by transplantation of a well-defined somatic stem cell from human umbilical cord blood. Brain 135:431-446.
41. Karalija A, LN Novikova, PJ Kingham, M Wiberg and LN Novikov. (2012). Neuroprotective effects of N-acetylcysteine and acetyl-l-carnitine after spinal cord injury in adult rats. PLoS One 7:e41086.
42. Novikova LN, S Lobov, M Wiberg and LN Novikov. (2011). Efficacy of olfactory ensheathing cells to support regeneration after spinal cord injury is influenced by method of culture preparation. Exp Neurol 229:132-142.
43. Schallert T, SM Fleming, JL Leasure, JL Tillerson and ST Bland. (2000). CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39:777-787.
44. Muir GD, AA Webb, S Kanagal and L Taylor. (2007). Dorsolateral cervical spinal injury differentially affects forelimb and hindlimb action in rats. Eur J Neurosci 25: 1501-1510.
45. Sahni V and JA Kessler. (2010). Stem cell therapies for spinal cord injury. Nat Rev Neurol 6:363-372.
46. Yuan YM and C He. (2013). The glial scar in spinal cord injury and repair. Neurosci Bull 29:421-435.
47. Grimpe B, Y Pressman, MD Lupa, KP Horn, MB Bunge and J Silver. (2005). The role of proteoglycans in Schwann cell/astrocyte interactions and in regeneration failure at PNS/CNS interfaces. Mol Cell Neurosci 28:18-29.
48. McTigue DM, PJ Horner, BT Stokes and FH Gage. (1998). Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci 18:5354-5365.
49. Vavrek R, J Girgis, W Tetzlaff, GW Hiebert and K Fouad. (2006). BDNF promotes connections of corticospinal neurons onto spared descending interneurons in spinal cord injured rats. Brain 129:1534-1545.
50. Sasaki M, C Radtke, AM Tan, P Zhao, H Hamada, K Houkin, O Honmou and JD Kocsis. (2009). BDNFhypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J Neurosci 29:14932-14941.
51. Baird A. (1994). Fibroblast growth factors: activities and significance of non-neurotrophin neurotrophic growth factors. Curr Opin Neurobiol 4:78-86.
52. Walicke PA. (1988). Basic and acidic fibroblast growth factors have trophic effects on neurons from multiple CNS regions. J Neurosci 8:2618-2627.
53. Mattson MP and SW Scheff. (1994). Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapy. J Neurotrauma 11: 3-33.
54. Moskowitz MAE and LRE Caplan. (1995). Cerebrovascular Diseases: 19th Princeton Stroke Conference: Papers. Oxford: Butterworth-Heinemann.
55. Macaya DJ, K Hayakawa, K Arai and M Spector. (2013). Astrocyte infiltration into injectable collagen-based hydrogels containing FGF-2 to treat spinal cord injury. Biomaterials 34:3591-3602.
56. Widenfalk J, A Lipson, M Jubran, C Hofstetter, T Ebendal, Y Cao and L Olson. (2003). Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience 120:951-960.
57. Sondell M, G Lundborg and M Kanje. (1999). Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 19:5731-5740.
58. Hawryluk GW, AJ Mothe, M Chamankhah, J Wang, C Tator and MG Fehlings. (2012). In vitro characterization of trophic factor expression in neural precursor cells. Stem Cells Dev 21:432-447.
59. Hawryluk GW, A Mothe, J Wang, S Wang, C Tator and MG Fehlings. (2012). An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev 21:2222-2238.
60. Li Y, J Chen, XG Chen, L Wang, SC Gautam, YX Xu, M Katakowski, LJ Zhang, M Lu, N Janakiraman and M Chopp. (2002). Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59:514-523.
61. Zhang J, Y Li, J Chen, M Yang, M Katakowski, M Lu and M Chopp. (2004). Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells. Brain Res 1030:19-27.
62. Uccelli A, F Benvenuto, A Laroni and D Giunti. (2011). Neuroprotective features of mesenchymal stem cells. Best Pract Res Clin Haematol 24:59-64.
63. Vercelli A, OM Mereuta, D Garbossa, G Muraca, K Mareschi, D Rustichelli, I Ferrero, L Mazzini, E Madon and F Fagioli. (2008). Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 31:395-405.
64. Banas A, T Teratani, Y Yamamoto, M Tokuhara, F Takeshita, M Osaki, M Kawamata, T Kato, H Okochi and T Ochiya. (2008). IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 26:2705-2712.
65. Kim HJ and GI Im. (2009). Chondrogenic differentiation of adipose tissue-derived mesenchymal stem cells: greater doses of growth factor are necessary. J Orthop Res 27:612-619.
66. Yi JH, Y Katagiri, B Susarla, D Figge, AJ Symes and HM Geller. (2012). Alterations in sulfated chondroitin glycosaminoglycans following controlled cortical impact injury in mice. J Comp Neurol 520:3295-3313.
67. Massey JM, CH Hubscher, MR Wagoner, JA Decker, J Amps, J Silver and SM Onifer. (2006). Chondroitinase ABC digestion of the perineuronal net promotes functional collateral sprouting in the cuneate nucleus after cervical spinal cord injury. J Neurosci 26:4406-4414.
68. Hawthorne AL, H Hu, B Kundu, MP Steinmetz, CJ Wylie, ES Deneris and J Silver. (2011). The unusual response of serotonergic neurons after CNS Injury: lack of axonal dieback and enhanced sprouting within the inhibitory environment of the glial scar. J Neurosci 31:5605-5616.
69. Fitch MT and J Silver. (2008). CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp Neurol 209:294-301.
70. Harel NY and SM Strittmatter. (2006). Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury? Nat Rev Neurosci 7:603-616.
71. Ryu HH, BJ Kang, SS Park, Y Kim, GJ Sung, HM Woo, WH Kim and OK Kweon. (2012). Comparison of mesenchymal stem cells derived from fat, bone marrow, Wharton's jelly, and umbilical cord blood for treating spinal cord injuries in dogs. J Vet Med Sci 74:1617-1630.
72. Lim SN, W Huang, JC Hall, AT Michael-Titus and JV Priestley. (2013). Improved outcome after spinal cord compression injury in mice treated with docosahexaenoic acid. Exp Neurol 239:13-27.
73. Jones LL, RU Margolis and MH Tuszynski. (2003). The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp Neurol 182:399-411.
74. Reilly JF, PA Maher and VG Kumari. (1998). Regulation of astrocyte GFAP expression by TGF-beta1 and FGF-2. Glia 22:202-210.
75. Weishaupt N, C Hurd, DZ Wei and K Fouad. (2013). Reticulospinal plasticity after cervical spinal cord injury in the rat involves withdrawal of projections below the injury. Exp Neurol 247C:241-249.
76. Zhilai Z, Z Hui, J Anmin, M Shaoxiong, Y Bo and C Yinhai. (2012). A combination of taxol infusion and human umbilical cord mesenchymal stem cells transplantation for the treatment of rat spinal cord injury. Brain Res 1481:79-89.
77. Mahmood A, H Wu, C Qu, Y Xiong and M Chopp. (2013). Effects of treating traumatic brain injury with collagen scaffolds and human bone marrow stromal cells on sprouting of corticospinal tract axons into the denervated side of the spinal cord. J Neurosurg 118:381-389.
78. Giger RJ, ER Hollis, 2nd and MH Tuszynski. (2010). Guidance molecules in axon regeneration. Cold Spring Harb Perspect Biol 2:a001867.
79. Tanga FY, V Raghavendra and JA DeLeo. (2004). Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem Int 45:397-407.
80. Popovich PG, P Wei and BT Stokes. (1997). Cellular inflammatory response after spinal cord injury in spraguedawley and lewis rats. J Comp Neurol 377:443-464.
81. Evans TA, DS Barkauskas, J Myers, EG Hare, J You, RM Ransohoff, AY Huang and J Silver. (2014). High-resolution intravital imaging reveals that blood-derived macrophages but not resident microglia facilitate secondary axonal dieback in traumatic spinal cord injury. Exp Neurol 254:109-120.
82. Choi JS, JW Leem, KH Lee, SS Kim, H Suh-Kim, SJ Jung, UJ Kim and BH Lee. (2012). Effects of human mesenchymal stem cell transplantation combined with polymer on functional recovery following spinal cord hemisection in rats. Korean J Physiol Pharmacol 16:405-411.
83. Roh DH, MS Seo, HS Choi, SB Park, HJ Han, AJ Beitz, KS Kang and JH Lee. (2013). Transplantation of human umbilical cord blood or amniotic epithelial stem cells alleviates mechanical allodynia after spinal cord injury in rats. Cell Transplant 22:1577-1590.
84. Liu J, J Chen, B Liu, C Yang, D Xie, X Zheng, S Xu, T Chen, L Wang, et al. (2013). Acellular spinal cord scaffold seeded with mesenchymal stem cells promotes longdistance axon regeneration and functional recovery in spinal cord injured rats. J Neurol Sci 325:127-136.
85. Hollis ER, 2nd and MH Tuszynski. (2011). Neurotrophins: potential therapeutic tools for the treatment of spinal cord injury. Neurotherapeutics 8:694-703.
86. Deumens R, GC Koopmans and EA Joosten. (2005). Regeneration of descending axon tracts after spinal cord injury. Prog Neurobiol 77:57-89.
87. Pluchino S and C Cossetti. (2013). How stem cells speak with host immune cells in inflammatory brain diseases. Glia 61:1379-1401.
88. Fric J, T Zelante, AY Wong, A Mertes, HB Yu and P Ricciardi-Castagnoli. (2012). NFAT control of innate immunity. Blood 120:1380-1389.
89. Shi D, L Liao, B Zhang, R Liu, X Dou, J Li, X Zhu, L Yu, D Chen and RC Zhao. (2011). Human adipose tissuederived mesenchymal stem cells facilitate the immunosuppressive effect of cyclosporin A on T lymphocytes through Jagged-1-mediated inhibition of NF-kappaB signaling. Exp Hematol 39:214-224.
90. Oh JS, IS Park, KN Kim, H Yoon do, SH Kim and Y Ha. (2012). Transplantation of an adipose stem cell cluster in a spinal cord injury. Neuroreport 23:277-282.
91. Forostyak S, P Jendelova and E Sykova. (2013). The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications. Biochimie 95:2257-2270.
92. Nacev BA and JO Liu. (2011). Synergistic inhibition of endothelial cell proliferation, tube formation, and sprouting by cyclosporin A and itraconazole. PLoS One 6:e24793.